Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response. [electronic resource]
Producer: 20151029Description: e100207 p. digitalISSN:- 1932-6203
- Alanine Transaminase -- metabolism
- Antiviral Agents -- therapeutic use
- Cross-Sectional Studies
- Fatty Liver -- drug therapy
- Female
- Follow-Up Studies
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Polymerase Chain Reaction
- Prognosis
- RNA, Viral -- genetics
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- Viral Load
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.